Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　― A Predetermined Companion Report From the ONCO PE Trial ―-Reference-Cited by-同舟云学术

Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　― A Predetermined Companion Report From the ONCO PE Trial ―

Published:2024-03-08 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Chatani Ryuki¹,Yamashita Yugo²,Morimoto Takeshi³,Muraoka Nao⁴,Shioyama Wataru⁵,Shibata Tatsuhiro⁶,Nishimoto Yuji⁷,Ogihara Yoshito⁸,Doi Kosuke⁹,Oi Maki¹⁰,Shiga Taro¹¹,Sueta Daisuke¹²,Kim Kitae¹³,Tanabe Yasuhiro¹⁴,Koitabashi Norimichi¹⁵,Takada Takuma¹⁶,Ikeda Satoshi¹⁷,Nakagawa Hitoshi¹⁸,Mitsuhashi Takayuki¹⁹,Shoji Masaaki²⁰,Sakamoto Jiro²¹,Hisatake Shinji²²,Ogino Yutaka²³,Fujita Masashi²⁴,Nakanishi Naohiko²⁵,Dohke Tomohiro²⁶,Hiramori Seiichi²⁷,Nawada Ryuzo²⁸,Kaneda Kazuhisa²⁹,Mushiake Kazunori¹,Yamamoto Hiromi¹,Kadota Kazushige¹,Ono Koh²,Kimura Takeshi³⁰,

Affiliation:

1. Department of Cardiovascular Medicine, Kurashiki Central Hospital

2. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

3. Department of Clinical Epidemiology, Hyogo Medical University

4. Division of Cardiology, Shizuoka Cancer Center

5. Department of Cardiovascular Medicine, Shiga University of Medical Science

6. Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine

7. Division of Cardiology, Osaka General Medical Center

8. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine

9. Department of Cardiology, National Hospital Organization Kyoto Medical Center

10. Department of Cardiology, Japanese Red Cross Otsu Hospital

11. Department of Onco-Cardiology/Cardiovascular Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research

12. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

13. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital

14. Department of Cardiology, St. Marianna University School of Medicine

15. Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine

16. Department of Cardiology, Tokyo Women’s Medical University

17. Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences

18. Department of Cardiovascular Medicine, Nara Medical University

19. Division of Cardiology, Fujisawa City Hospital

20. Department of Cardiovascular Medicine, National Cancer Center Hospital

21. Department of Cardiology, Tenri Hospital

22. Division of Cardiovascular Medicine, Toho University Omori Medical Center

23. Department of Cardiology, Yokohama City University

24. Department of Onco-Cardiology, Osaka International Cancer Institute

25. Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

26. Division of Cardiology, Kohka Public Hospital

27. Department of Cardiology, Kokura Memorial Hospital

28. Department of Cardiology, Shizuoka City Shizuoka Hospital

29. Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital

30. Department of Cardiology, Hirakata Kohsai Hospital

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-24-0004/_pdf

Reference22 articles.

1. 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7–34.

2. 2. Ito Y, Miyashiro I, Ito H, Hosono S, Chihara D, Nakata-Yamada K, et al. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci 2014; 105: 1480–1486.

3. 3. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715–722.

4. 4. Roy PM, Penaloza A, Hugli O, Klok FA, Arnoux A, Elias A, et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: The HOME-PE randomized trial. Eur Heart J 2021; 42: 3146–3157.

5. 5. Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, et al. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor Rivaroxaban: An international multicentre single-arm clinical trial. Eur Heart J 2020; 41: 509–518.